AISAP Cardio vs Eko Murmur Analysis Software (EMAS)
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your clinical setting requires rapid, comprehensive, and quantitative cardiac diagnostic assessments directly at the point of care using ultrasound. This tool is ideal for clinicians needing AI-powered interpretation of POCUS to detect structural heart disease, heart failure, and specific valvular pathologies with detailed measurements and automated reporting. It excels when a full cardiac ultrasound assessment is necessary beyond just murmur detection.
View AISAP Cardio →Choose Eko Murmur Analysis Software (EMAS) if…
Choose Eko Murmur Analysis Software if you need an AI-powered solution for early detection and differentiation of heart murmurs using a digital stethoscope, particularly in primary care, urgent care, or telehealth environments. This tool is best suited for clinicians looking to augment their auscultation skills with AI-driven clinical decision support for heart and lung disease, providing a quick and accessible screening method. It focuses on enhancing the diagnostic capabilities of a physical exam.
View Eko Murmur Analysis Software (EMAS) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | Eko Murmur Analysis Software (EMAS) |
|---|---|---|
| Pricing | Unknown | Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. |
| Deployment | Cloud-based | Cloud-based, Mobile App |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed to make complex POCUS diagnostics accessible to a broader range of clinicians, including non-specialists, with real-time guidance to improve diagnostic accuracy and speed. While Eko Murmur Analysis Software offers a straightforward mobile app experience, some user feedback indicates potential issues with Bluetooth connectivity and data privacy concerns.
Clinical Value
AISAP CardioBoth tools are FDA-cleared and provide valuable clinical decision support. However, AISAP Cardio offers a comprehensive diagnostic assessment of structural heart disease and heart failure, including quantitative measurements like LVEF and valvular pathologies, which are more definitive diagnostic outputs. Eko Murmur Analysis Software focuses on murmur detection and differentiation, which serves more as a screening tool often leading to further diagnostic imaging.
Pricing & Value
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software offers a free tier for basic AI analysis, making it highly accessible for individual clinicians and for initial evaluation. AISAP Cardio's pricing is not publicly available, which is common for enterprise solutions but creates a higher barrier to entry and less transparency compared to Tool B's offering.
Enterprise Readiness
AISAP CardioAISAP Cardio explicitly highlights its vendor-agnostic nature, scalability, and seamless integration into PACS, EMRs, and telemedicine platforms, along with being HIPAA-compliant and ISO-certified. While Eko Murmur Analysis Software also confirms HIPAA compliance and BAA, and offers an enterprise platform (SENSORAu2122), Tool A's emphasis on deep integration with existing hospital imaging and information systems for a comprehensive diagnostic platform, and its adoption by major health systems, demonstrates a broader enterprise readiness for complex clinical environments.
Innovation
AISAP CardioAISAP Cardio is recognized as the 'first company in the world to secure FDA clearance in the CADx pathway for the comprehensive diagnosis of structural heart diseases using POCUS'. This represents a significant breakthrough in bringing advanced, comprehensive diagnostic capabilities to the point of care, empowering a wider range of clinicians to perform expert-level cardiac assessments, pushing the boundaries of POCUS significantly.
Support & Docs
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software provides extensive and easily accessible support documentation through its Eko Help Center, including user manuals, troubleshooting guides, FAQs, and options to schedule support calls. Specific support and documentation for AISAP Cardio were not readily found in public search results, making Tool B the clear winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | Eko Murmur Analysis Software (EMAS) |
|---|---|---|
| Name | AISAP Cardio | Eko Murmur Analysis Software (EMAS) |
| Company | Aisap | Eko Devices |
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and and pediatric patients, providing clinical decision support for early detection of heart and lung disease. |
| Primary Modality | Point-of-care ultrasound (POCUS) | Heart sound (PCG) and optional ECG data via digital stethoscopes |
| Key Features (Cardiac) | AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter | FDA-cleared AI for murmur detection, differentiates innocent and structural heart murmurs |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and Eko Murmur Analysis Software (EMAS).